Morphosys Ag Asset Turnover Ratio (MOR), as of fourth quarter 2023, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Morphosys Ag  (NASDAQ: MOR)
 

Morphosys Ag Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Due to the increase in investments during the fourth quarter 2023, Morphosys Ag's asset turnover ratio sequentially decreased to 0.11 in the fourth quarter (Dec 31 2023), this is lower than usual.

Within sector 183 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2023 compared to the preceding quarter from 2353 to 3482.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MOR Asset Turnover Ratio (Dec 31 2023)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2022)
IV. Quarter
Y / Y Asset Change -11.24 % -15.46 % -15.46 % -15.46 % -5.36 %
Y / Y Revenue Change -14.37 % - - - 54.93 %
Asset Turnover Ratio (TTM) 0.11 - - - 0.11
MOR's Total Ranking # 3482 # 2353 # 3403 # 0 # 2962
Seq. Asset Change 45.43 % 0 % 0 % -38.96 % 38.5 %
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 184
Healthcare Sector # 502
Overall Market # 3482

Asset Turnover Ratio Statistics
High Average Low
0.2 0.13 0.07
(Dec 31 2020)   (Dec 31 2021)




MOR Company Profile • Back to MOR Efficiency Comparisons • Compare MOR Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2023, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2023 Assets at quarter ending Dec 31 2023
Neurometrix Inc   0.22 $ 4.947  Millions$ 22.274  Millions
Poseida Therapeutics Inc   0.22 $ 64.703  Millions$ 292.743  Millions
Insmed Inc  0.22 $ 305.528  Millions$ 1,402.892  Millions
Eyepoint Inc   0.22 $ 46.018  Millions$ 211.369  Millions
Fulgent Genetics Inc   0.22 $ 288.456  Millions$ 1,331.268  Millions
Clearside Biomedical Inc   0.22 $ 8.226  Millions$ 38.080  Millions
Genfit S a   0.21 $ 41.294  Millions$ 192.337  Millions
Intelligent Bio Solutions Inc   0.21 $ 2.149  Millions$ 10.020  Millions
Bio rad Laboratories Inc   0.21 $ 2,670.946  Millions$ 12,460.164  Millions
Pulmatrix Inc   0.21 $ 7.298  Millions$ 34.545  Millions
Xencor Inc  0.21 $ 174.615  Millions$ 831.274  Millions
Zevra Therapeutics Inc   0.21 $ 27.461  Millions$ 130.856  Millions
Renalytix Plc  0.21 $ 5.295  Millions$ 25.312  Millions
Alpine Immune Sciences Inc   0.21 $ 58.876  Millions$ 283.834  Millions
Lifeward ltd   0.21 $ 13.854  Millions$ 66.800  Millions
Xenetic Biosciences Inc   0.21 $ 2.540  Millions$ 12.258  Millions
Seelos Therapeutics inc   0.20 $ 2.401  Millions$ 11.792  Millions
Neogen Corporation  0.20 $ 917.963  Millions$ 4,544.683  Millions
Adaptimmune Therapeutics Plc  0.20 $ 60.281  Millions$ 302.580  Millions
Capforce Inc   0.20 $ 3.418  Millions$ 17.241  Millions
Valion Bio Inc   0.20 $ 1.176  Millions$ 5.965  Millions
Icecure Medical Ltd  0.20 $ 3.229  Millions$ 16.410  Millions
T2 Biosystems Inc   0.19 $ 7.193  Millions$ 36.985  Millions
Jaguar Health Inc   0.19 $ 9.761  Millions$ 51.311  Millions
Butterfly Network Inc   0.19 $ 65.856  Millions$ 346.191  Millions
Nektar Therapeutics  0.19 $ 90.122  Millions$ 474.075  Millions
Dariohealth Corp   0.19 $ 19.984  Millions$ 107.016  Millions
Macrogenics Inc   0.18 $ 58.749  Millions$ 321.885  Millions
Arcutis Biotherapeutics Inc   0.18 $ 59.606  Millions$ 333.618  Millions
Petros Pharmaceuticals inc   0.18 $ 5.822  Millions$ 33.002  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.